Drugs and Drug Candidates MDPI

27/11/2025

27/11/2025

Kandhare et al. review how and ML are transforming pharma —accelerating drug discovery, enhancing clinical trials, boosting safety, and enabling medicine. 🤖💊

Read more at:

Background/Objectives: The integration of Artificial Intelligence (AI) and Machine Learning (ML) in pharmaceutical research and development is transforming the industry by improving efficiency and effectiveness across drug discovery, development, and healthcare delivery. This review explores the div...

26/11/2025

🚨 We're thrilled to announce our participation in the 5th Alpine Winter Conference on Medicinal and Synthetic Chemistry ⭐

📌St. Anton, Austria
🗓️ 25–29 January 2026

For additional details about the conference, please click on the following link: https://brnw.ch/21wXQVF

25/11/2025

Recognized annually from 18-24 November, World AMR Awareness Week calls attention to the urgent global challenge of 🦠

With this year's theme of "Act Now: Protect Our Present, Secure our Future", World AMR Awareness Week 2025 calls for sustained action to preserve the effectiveness of life-saving antimicrobials.

We are pleased to share a curated selection of related research published across a variety of journals, including studies on novel antibiotics, resistance mechanisms, diagnostic tools, infection control, and global policy frameworks.

Access the research 👇

World AMR Awareness Day 2025 draws attention to the urgent global challenge of antimicrobial resistance (AMR)—one of the greatest threats...

24/11/2025

Professor DiMarchi discusses his career, advice for young scholars, and what being a co-recipient of the 2024 Tu Youyou Award means to him.

21/11/2025

📢 We are delighted to announce that Prof. Dr. Wen Liu from Shanghai Institute of Organic Chemistry, China, will serve as a Keynote Speaker for the session on “Biocatalysis for Natural Product and Drug Synthesis” at the 5th Medicinal Chemistry Symposium ( ): New Trends in Chemical Biology and Drug Discovery, which will be held in , China, from May 14 to 17, 2026.

🎤 Prof. Liu is a Professor at the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, CAS / 中国科学院 / 중국과학원. His research focuses on the biosynthesis of natural products, including the establishment of metabolic pathways, elucidation of novel enzymatic mechanisms, and key scientific theories and methodologies for the industrialization of bulk antibiotic products.

✨ Don't miss the opportunity to interact with Prof. Liu!
📝 Submit your abstracts here: https://brnw.ch/21wXCXu

14/11/2025

🚀 We are thrilled to be part of the British Pharmacological Society’s annual Pharmacology 2025 conference, and our delegates are eager to meet you at booth #12.

📅 16–18 December 2025
📌 Belfast, UK

We can’t wait to share the exciting advancements we’re working on!

For more details, please check the website:
https://brnw.ch/21wXuB3

10/11/2025

📢 We are delighted to announce that Prof. Dr. Christophe Rochais from Université de Caen Normandie (University of Caen Normandy), France, will serve as a Keynote Speaker for the session on “Drug Discovery Targeting GPCRs and Ion Channels” at the 5th Medicinal Chemistry Symposium ( ): New Trends in Chemical Biology and Drug Discovery, which will be held in , China, from May 14 to 17, 2026.

🎤 Prof. Christophe Rochais is a professor in organic chemistry at the University of Caen Normandy, and a member of the French National Academy of Pharmacy. His research interests include medicinal chemistry programs in the field of enzymatic inhibition and receptor modulation, aiming to develop pharmacological tools and bioactive compounds. He leads a research group dedicated to developing polypharmacology approaches for the treatment of neurodegenerative and infectious diseases.

✨ Don't miss the opportunity to interact with Prof. Christophe Rochais!
📝 Submit your abstracts here: https://brnw.ch/21wXdJE

05/11/2025

📢 We are thrilled to be part of the 18th China Pharmaceutical Preparation Conference and our delegates are eager to meet you in person at booth .

📆 21–23 November 2025
📌 Nanjing, China

More details could be found at: https://brnw.ch/21wXdR9

31/10/2025

Alquisiras-Burgos et al. have reviewed how nose-to-brain delivery of using advanced offers a promising, non-invasive strategy for treating . 🧪

Read more:

Cerebral ischemia represents a particular condition among neurological diseases due to its high frequency, high associated mortality, and the permanent disability in patients that survive it. Numerous studies in animal models have demonstrated the protective properties of resveratrol against cerebra...

30/10/2025

Mohapatra et al. have reviewed how , originally cancer drugs, are being repurposed to combat parasites like malaria and leishmaniasis, highlighting new opportunities and challenges in therapy. 🧪

Read more: https://www.mdpi.com/2813-2998/3/1/6

29/10/2025

🌼 New research reveals , a minor curcuminoid from turmeric, as a promising stimulator of synthesis and export, offering potential for treating hypopigmentary disorders. ✨

Read more at:

Effective therapies to treat skin hypopigmentation disorders caused by diminished melanin synthesis or export are limited due to potential side effects. In this work, we explored if cyclocurcumin (C*C), a curcuminoid found in minor amounts in turmeric rhizomes, might enhance the process of melanogen...